SESSA, Rosa
 Distribuzione geografica
Continente #
NA - Nord America 4.076
EU - Europa 884
AS - Asia 388
AF - Africa 38
SA - Sud America 28
OC - Oceania 2
Totale 5.416
Nazione #
US - Stati Uniti d'America 4.060
IT - Italia 336
IN - India 210
CN - Cina 166
SE - Svezia 115
UA - Ucraina 111
FI - Finlandia 87
DE - Germania 53
GB - Regno Unito 52
NL - Olanda 34
TG - Togo 32
IE - Irlanda 30
BE - Belgio 28
AR - Argentina 26
FR - Francia 21
CA - Canada 16
SG - Singapore 6
RO - Romania 5
JP - Giappone 4
ZA - Sudafrica 4
CH - Svizzera 3
ES - Italia 3
PL - Polonia 3
BR - Brasile 2
SC - Seychelles 2
AU - Australia 1
DK - Danimarca 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
TH - Thailandia 1
TR - Turchia 1
Totale 5.416
Città #
Fairfield 578
Chandler 403
Ashburn 301
Houston 249
Woodbridge 240
Seattle 230
Dearborn 195
Cambridge 188
Ann Arbor 181
Wilmington 174
Rome 155
Princeton 111
Beijing 92
Plano 91
New York 87
Lawrence 76
San Paolo di Civitate 64
Boston 58
San Diego 53
Millbury 42
Jacksonville 39
Andover 38
Lomé 32
Maastricht 27
Federal 26
Brussels 25
Dublin 25
Fremont 25
San Mateo 21
Norwalk 19
Boardman 18
Bremen 17
Civitavecchia 16
Des Moines 14
Hefei 13
Nanjing 13
London 10
Phoenix 9
Falls Church 8
Ottawa 8
Southend 7
Toronto 7
Pune 6
Chicago 5
Guangzhou 5
Kunming 5
Menlo Park 5
Philadelphia 5
Buffalo 4
Chengdu 4
Nanchang 4
Washington 4
Altamura 3
Amsterdam 3
Bartlesville 3
Colombes 3
Hangzhou 3
Helsinki 3
Jinan 3
Lanciano 3
Lappeenranta 3
Redmond 3
San Francisco 3
Xian 3
Aversa 2
Bern 2
Brugherio 2
Castelgomberto 2
Fasano 2
Fuzhou 2
Granada 2
Göttingen 2
Indiana 2
Koersel 2
Mahé 2
Milan 2
Mountain View 2
Muizenberg 2
Ostseebad Dierhagen 2
Palermo 2
Sarno 2
Shaoxing 2
Shenyang 2
Silverton 2
Tokyo 2
Warsaw 2
Aci Sant'antonio 1
Acquaviva Delle Fonti 1
Acquaviva delle Fonti 1
Allennes-les-marais 1
Anacapri 1
Anaheim 1
Auburn Hills 1
Auckland 1
Baiano 1
Bangkok 1
Bellante 1
Berlin 1
Birmingham 1
Bonn 1
Totale 4.126
Nome #
Infectious burden and atherosclerosis. A clinical issue 117
A simple, fast and reliable scan-based technique as a novel approach to quantify intracellular bacteria 105
Lactobacilli-lactoferrin interplay in Chlamydia trachomatis infection 104
Chlamydia pneumoniae-mediated inflammation in atherosclerosis: a meta-analysis. 95
Biofilm in genital ecosystem: a potential risk factor for Chlamydia trachomatis infection. 93
Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C 93
Chlamydia pneumoniae clinical isolate from gingival crevicular fluid. A potential atherogenic strain 90
Detection of Borrelia burgdorferi sensu lato DNA by PCR in serum of patients with clinical symptoms of Lyme borreliosis. 86
Effects of Mentha suaveolens essential oil on C. trachomatis 83
Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability 81
Chlamydia pneumoniae in asymptomatic carotid atherosclerosis 80
Diversity of cervical microbiota in asymptomatic chlamydia trachomatis genital infection: a pilot study 78
Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: A brief overview 77
Chlamydia pneumoniae as risk factor of cardiovascular disease in dialysis patients 76
Apyrase, the product of the virulence plasmid-encoded phoN2 (apy) gene of Shigella flexneri, is necessary for proper unipolar IcsA localization and for efficient intercellular spread 76
Growth kinetics of Chlamydia trachomatis in primary human Sertoli cells 76
Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae 75
Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center 74
Chlamydia pneumoniae and oxidative stress in cardiovascular disease. State of the art and prevention strategies. 73
Selected immunological mediators and cervical microbial signatures in women with chlamydia trachomatis infection 73
Chlamydia pneumoniae in PBMC: Reproducibility of the OMPA nested touchdown PCR 72
Detection of different borrelia Burgdorferi genospecies in serum of people with different occupational risks: Short report 72
CHLAMYDIA PNEUMONIAE AND ATHEROSCLEROSIS: CURRENT STATE AND FUTURE PROSPECTIVES 71
Antibacterial activity and impact of different antiseptics on biofilm-contaminated implant surfaces 71
Melaleuca alternifolia essential oil possesses potent anti-staphylococcal activity extended to strains resistant to antibiotics 70
Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease 70
Effect of amino acid starvation on glucose transport in two archaeal organisms 69
Chlamydia pneumoniae and chronic diseases with a great impact on public health 69
Borrelia burgdorferi s.l. and Ehrlichia chaffeensis in the National Park of Abruzzo 69
Chlamydia trachomatis elicits TLR3 expression but disrupts the inflammatory signaling down-modulating NFκB and IRF3 transcription factors in human Sertoli cells 69
Interferon-γ possesses anti-microbial and immunomodulatory activity on a Chlamydia Trachomatis infection model of primary human synovial fibroblasts 68
Agenti infettivi nella patogenesi della cardiopatia ischemica 66
Chlamydia pneumoniae infection and atherosclerotic coronary disease 66
Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis 64
Could Chlamydia pneumoniae be considered an infectious risk factor for inflammatory diseases such as atherosclerosis? 64
Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host. Latest advances and future prospective. 64
Stringent control in the archaeal genus Sulfolobus 64
Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries 63
Prevalence of Clamydia pneumoniae in peripheral blood mononuclear cells in italian patients with acute ischaemic heart disease 63
Effects of vaginal lactobacilli in Chlamydia trachomatis infection 62
Multicentric study of seroprevalence of Borrelia burgdorferi and anaplasma phagocytophila in high-risk groups in regions of central and southern Italy 61
The elusive but pathogenic peptidoglycan of chlamydiae 58
Epidemiology of urogenital infections caused by Chlamydia trachomatis and outline of characteristic features of patients at risk. 58
[Chlamydia pneumoniae infection and cardiac ischemic syndromes]. 58
Lyme borreliosis infection in Europe. 57
Chlamydia pneumoniae and osteoporosis-associated bone loss: A new risk factor? 57
No evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction 57
Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis 57
Prevalence of IgG antibodies against Borrelia burgdorferi SL and Ehrlichia phagocytophila in sera of patients presenting symptoms of Lyme disease in a central region of Italy 57
Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients 54
In vitro susceptibility of isolates of Borrelia burgdorferi s.l. to antimicrobial agents 52
What is the Hidden Biological Mechanism Underlying the Possible SARS-CoV-2 Vertical Transmission? A Mini Review 52
CHLAMYDIA PNEUMONIAE AND ATHEROSCLEROSIS: THE ROLE OF MAST CELLS 51
Infectious agents in atherosclerotic cardiovascular diseases through oxidative stress 51
Human colonic myogenic dysfunction induced by mucosal lipopolysaccharide translocation and oxidative stress 51
Effect of bovine lactoferrin on chlamydia trachomatis infection and inflammation. 50
CUTANEOUS INFECTION OF NOCARDIA ALTAMIRENSIS: THE FIRST CASE REPORT 49
Genotyping of different Pseudomonas aeruginosa morphotypes arising from the lower respiratory tract of a patient taken to an Intensive Care Unit 49
Detection of four Borrelia burgdorferi genospecies and first report of human granulocytic ehrlichiosis agent in Ixodes ricinus ticks collected in central Italy 45
HPV/Chlamydia trachomatis co-infection. Metagenomic analysis of cervical microbiota in asymptomatic women 45
New insights into Chlamydiae persistence: An energy metabolism strategy? 45
Bacterial anti-Ig activity. 44
Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease 44
ASPETTI MOLECOLARI DELLA FORMA PERSISTENTE DI CHLAMYDIA PNEUMONIAE 43
Biofilm formation on the surface of ceramic tiles 43
Evaluation by real-time PCR of the expression of S. flexneri virulence-associated genes ospB and phoN2 under different genetical background 42
Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha. 42
Extra virgin olive oil-based green formulations with promising antimicrobial activity against drug-resistant isolates 42
In vivo and in vitro assessment of the virulence of Listeria monocytogenes strains 41
In vitro modelling of Chlamydia trachomatis infection in the Etiopathogenesis of male infertility and reactive arthritis 41
Chlamydia pneumoniae infection in patients with acute coronary syndrome: A clinical and serological 1-year follow-up 40
Determination of antibodies to Borrelia burgdorferi in the serum of patients living in Calabria, Southern Italy 39
Ruolo dell’infezione da Chlamydia pneumoniae in pazienti con angina instabile 39
Therapeutic potential of resveratrol against emerging respiratory viral infections 39
In-cell western assay as a high-throughput approach for Chlamydia trachomatis quantification and susceptibility testing to antimicrobials 38
Chlamydiae. Nota II: Chlamydia trachomatis. 37
[Infective agents in the pathogenesis of ischemic cardiopathy]. 37
CHLAMYDIA TRACHOMATIS INFECTION IN OBSTETRICS AND GYNAECOLOGY; THE ITALIAN EXPERIENCE 37
Ruolo dell’infezione da Chlamydia Pneumoniae nella cardiopatia ischemica giovanile 34
AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis 34
Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain? 34
Towards a Deeper Understanding of Chlamydia trachomatis Pathogenetic Mechanisms: Editorial to the Special Issue “Chlamydia trachomatis Pathogenicity and Disease” 34
The major epidemic infections: A gift from the old world to the new? 33
Lyme borreliosis in Central Italy (1995-1998) 33
Potential IFNγ modulation of inflammasome pathway in Chlamydia trachomatis infected synovial cells 33
EPIDEMIOLOGICAL AND THERAPEUTICAL OBSERVATIONS ON CHLAMYDIA TRACHOMATIS INFECTIONS IN GYNECOLOGICAL PATIENTS IN ROME 32
the link between Clamydia pneumoniae infection and abdominal aortic aneurysms: a problem still to solve. 31
Oxidative Stress and Inflammation in SARS-CoV-2- and Chlamydia pneumoniae-Associated Cardiovascular Diseases 31
The potential role of hypochlorhydria in the development of duodenal dysbiosis. A preliminary report 31
CHLAMYDIA PNEUMONIAE INFECTION AS A RISK FACTOR FOR ACCELERATED ATHEROSCLEROSIS IN HEMODIALYSIS PATIENTS 30
Clinical and Epidemiological Observations on Chlamydia Trachomatis infections 30
Chlamydiae. Nota I. 28
RESISTANCE SURVELLANCE IN ITALY: FOUR-YEAR RESULTS FROM THE MYSTIC PROGRAM 28
RESVERATROL IN CHLAMYDIA PNEUMONIAE-INDUCED FOAM CELL FORMATION AND INTERLEUKIN-17A SYNTHESIS 27
Prevalence of Borrelia burgdorferi sensu lato genomospecies and of the human granulocytic ehrlichiosis (HE) agent in Ixodes ricinus ticks collected in the area of Monti Lepini, Italy. 27
SARS-CoV-2 vertical transmission in a twin-pregnant woman. A case report 25
Effect of bovine serum, hyaluronic acid and netilmicine on the in vitro adhesion of bacteria isolated from human-worn disposable soft contact lenses. 25
Lyme disease seroprevalence in a region of central Italy. 25
SARS-CoV-2 infection in pregnancy. Clues and proof of adverse outcomes 21
Geographical incidence of infection with Borrelia burgdorferi in Europe 21
Totale 5.500
Categoria #
all - tutte 13.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019532 0 0 0 0 0 0 2 21 11 93 221 184
2019/20201.387 178 45 13 81 139 216 195 159 128 133 67 33
2020/2021461 47 38 40 40 27 37 8 50 67 54 33 20
2021/20221.195 17 67 89 48 128 14 17 113 94 92 303 213
2022/20231.244 203 279 53 161 123 103 18 87 128 17 36 36
2023/2024424 42 95 32 79 53 123 0 0 0 0 0 0
Totale 5.702